Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Shuai Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-8796-4606; OpenAlex author ID A5146895546. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. TGM2-P2RX7 loop promotes gemcitabine resistance in pancreatic cancer by modulating glutamine metabolism and mitophagy. Last author DOI 10.1038/s41420-025-02922-x↗
  2. Corrigendum to "Long Noncoding RNA TUG1/miR-29c Axis Affects Cell Proliferation, Invasion, and Migration in Human Pancreatic Cancer". Co-author DOI 10.1155/2021/5150272↗
  3. HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling. First author DOI 10.1002/jcb.26395↗
  4. Long Noncoding RNA TUG1/miR-29c Axis Affects Cell Proliferation, Invasion, and Migration in Human Pancreatic Cancer. Co-author DOI 10.1155/2018/6857042↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuejun Gong · 1 shared paper, 2025 · strength 0.30
  2. Ke Ye · 1 shared paper, 2025 · strength 0.30
  3. Yebin Lu · 2 shared papers, 2018–2021 · strength 0.22
  4. Wei Wei · 2 shared papers, 2018–2021 · strength 0.22
  5. Yaqun Yu · 1 shared paper, 2019 · strength 0.11
  6. Yixiong Li · 1 shared paper, 2019 · strength 0.11
  7. Weijia Liao · 1 shared paper, 2019 · strength 0.11
  8. Zhipeng Zhang · 1 shared paper, 2018 · strength 0.08
  9. Ling Tang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.